Market Analysis and Price Projections for NDC: 42543-0961 (Cinacalcet)
Overview of NDC 42543-0961
The National Drug Code (NDC) 42543-0961 corresponds to Cinacalcet, a medication manufactured by Strides Pharma Inc. Cinacalcet is used primarily to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia in patients with parathyroid carcinoma[5].
Market Context
Biopharma and Biotech Market Growth
The biopharma and biotech industries are experiencing significant growth, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].
Drug Pricing Trends
Prescription drug prices, particularly for brand-name and biologic drugs, have been increasing steadily. Annual price increases often range from 10% to 20%, attributed to factors such as rebates, co-pay assistance programs, research and development costs, and shareholder obligations[4].
Pricing of Cinacalcet (NDC 42543-0961)
Current Pricing
As of the latest available data, the pricing for Cinacalcet can vary based on the specific formulation and dosage. However, detailed pricing information for NDC 42543-0961 is not provided in the sources. Generally, prices for medications like Cinacalcet can be influenced by factors such as production costs, market competition, and regulatory environments.
Price Comparison
To understand the pricing dynamics, it is useful to compare with other medications. For instance, drugs like Actemra and Benlysta, which are also used for specific therapeutic areas, have prices that range from hundreds to thousands of dollars per unit or dose[2].
Factors Influencing Price Projections
Regulatory Environment
The regulatory landscape is evolving to keep pace with innovation in the biopharma and biotech industries. Changes in regulatory frameworks can impact drug pricing by affecting the cost of compliance, approval processes, and market access[3].
Market Competition
The presence of competitors in the market significantly influences drug pricing. For Cinacalcet, the competition from other manufacturers and potential generic versions can drive prices down. However, as a branded drug, it often retains a premium price due to its efficacy and market demand.
Technological Advancements
Advancements in clinical trial designs and the use of AI/ML technologies can reduce the cost of drug development and potentially lower prices. However, these benefits may not immediately translate to lower consumer prices due to various market and regulatory factors[3].
Price Projections
Short-Term Projections
In the short term, prices for Cinacalcet (NDC 42543-0961) are likely to follow the general trend of moderate increases, potentially in the range of 10% to 20% annually, aligning with industry-wide price increase patterns[4].
Long-Term Projections
Long-term projections suggest that while the biopharma and biotech industries will continue to grow, there may be increased pressure to control drug prices. This could be driven by regulatory changes, increased competition from generics or biosimilars, and greater transparency in drug pricing. As a result, the price growth for Cinacalcet might stabilize or even decrease over the long term.
Key Takeaways
- Market Growth: The biopharma and biotech industries are experiencing rapid growth, which can influence the pricing dynamics of drugs like Cinacalcet.
- Pricing Trends: Annual price increases for prescription drugs, including Cinacalcet, are common and can range from 10% to 20%.
- Regulatory Impact: Evolving regulatory frameworks can affect drug pricing by influencing compliance costs and market access.
- Market Competition: Competition from other manufacturers and potential generic versions can impact the pricing of Cinacalcet.
- Technological Advancements: Innovations in clinical trials and AI/ML technologies may reduce development costs but may not immediately lower consumer prices.
FAQs
1. What is the primary use of Cinacalcet (NDC 42543-0961)?
Cinacalcet is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia in patients with parathyroid carcinoma.
2. How is the biopharma market expected to grow?
The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029.
3. What factors contribute to the annual price increases of prescription drugs?
Annual price increases are attributed to rebates, co-pay assistance programs, research and development costs, and obligations to shareholders.
4. How does market competition affect the pricing of Cinacalcet?
Market competition from other manufacturers and potential generic versions can drive prices down, but branded drugs like Cinacalcet often retain a premium price due to their efficacy and market demand.
5. What role do technological advancements play in drug pricing?
Technological advancements in clinical trials and AI/ML technologies can reduce development costs but may not immediately translate to lower consumer prices due to various market and regulatory factors.
Sources
- FDA's National Drug Code Directory - FDA
- MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023 - Missouri Department of Social Services
- 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
- Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services
- Strides Pharma Inc. - List of Drugs - NDC Labeler/Manufacturer - FindACode
